The discussion that started with a federal court overturning two gene patents continues as the biotech industry, researchers and lawyers debate the merits of the decision, the chances of an appeal, and the future of genetic research. As the debate continues, some say it's not really a big deal, and the emerging consensus is that this ruling may actually be a good thing if it forces companies to think outside the patent box and start innovating again.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.